LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs. LyGenesis’ lead preclinical program is focused on liver regeneration for patients with end stage liver disease. Other therapeutic targets for organ regeneration include the thymus, pancreas, and kidney. Privately held, LyGenesis is headquartered in Pittsburgh, Pennsylvania. To learn more, please visit our website at www.lygenesis.com.
Location: United States, Pennsylvania, Pittsburgh
Employees: 1-10
Total raised: $37M
Founded date: 2017
Investors 2
| Date | Name | Website |
| - | University... | innovation... |
| - | Longevity ... | lvf.vc |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 24.10.2023 | Series A | $19M | - |
| 29.12.2020 | - | $11M | - |
| 21.10.2019 | - | $4M | - |
| 10.05.2018 | Series A | $3M | - |
Mentions in press and media 12
| Date | Title | Description |
| 24.10.2023 | LyGenesis Raises $19M Series A-2 Round | PITTSBURGH, PA, LyGenesis has raised more than $19 million in a Series A-2 financing round. >> Click here for more funding data on LyGenesis >> To export LyGenesis funding data to PDF and Excel, click here LyGenesis, a cl... |
| 24.10.2023 | LyGenesis Raises $19M in Series A-2 Funding | Lygenesis hepatocytes are engrafted into the lymph node where they can proliferate and form a functioning ectopic liver inside the body. LyGenesis, a Pittsburgh, PA-based clinical-stage biotechnology company, raised $19M in Series A-2 fundi... |
| 21.10.2019 | LyGenesis Closes $4M Convertible Debt | PITTSBURGH, PA, Biotechnology company focused on organ regeneration, has completed a total of $4M in private financing of convertible notes. >> Click here for more funding data on LyGenesis >> To export LyGenesis funding dat... |
| 21.10.2019 | LyGenesis Closes $4 Million Convertible Debt Financing | LyGenesis, Inc., a biotechnology company focused on organ regeneration, announced today that they have completed a total of $4 million in private financing of convertible notes from Juvenescence, Ltd. and Longevity Vision Fund. Their techno... |
| 21.10.2019 | Biotech startup LyGenesis closes $4 million to begin clinical development of its liver regeneration technology | LyGenesis, a biotechnology startup company focused on organ regeneration, has closed $4 million to enable the company transition its lead program in liver regeneration into clinical development, beginning with a Phase 2a clinical trial for ... |
| 21.10.2019 | Top tech startup news for today, Monday, October 21, 2019 | Good morning! Below are some of the top tech startup news for today, Monday, October 21, 2019. Gojek announces co-CEOs after founder Makarim leaves to join Indonesia’s new cabinet. Indonesian tech startup Gojek announced a change in leader... |
| 21.10.2019 | LyGenesis Receives $4M Convertible Debt Financing | LyGenesis, Inc., a Pittsburgh, PA-based biotechnology company focused on organ regeneration, completed a total of $4m in private financing of convertible notes. The backers were Juvenescence, Ltd. and Longevity Vision Fund. This financing w... |
| 10.05.2018 | LyGenesis Raises $3m in Series A Financing | LyGenesis, Inc., a Pittsburgh, PA-based biotechnology company developing innovative technology for organ regeneration, raised $3m in Series A financing. Juvenescence, Ltd., made the investment. In conjunction with the funding, Greg Bailey, ... |
| 10.05.2018 | Term Sheet — Thursday, May 10 | BIG BUCKS Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From ExtraHop When I first saw the numbers in an email, I responded with a simple but necessary & appropriate: “holy crap.” Here are the final ... |
| 09.05.2018 | LyGenesis Closes $3M Series A Financing | PITTSBURGH, PA, Biotechnology company developing innovative technology for organ regeneration, announced today that they have raised $3 million in Series A financing. >> Click here for more funding data on LyGenesis >> To ex... |
Show more